October 20, 2020

NFLX Stock
US Equities

Cleveland BioLabs (CBLI) Escalates on Merger Agreement with Cytocom

Cleveland will combine with Cytocom in an all-stock transaction.  Cleveland BioLabs, Inc. (CBLI) shares are spiking today after it was reported that the company has signed a definitive merger agreement with, a leading biopharmaceutical company in the area of immune-modulation, Cytocom, Inc. Shares of Cleveland

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.